Concepedia
Pediatric Hematology and Oncology · 2014 · 21 citations · 15 references
The combination of irinotecan and vincristine has a significant antitumor activity and acceptable toxicity in children with relapsed HB.
15
Optimal two-stage designs for phase II clinical trials
Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations
Clinical Trial Management, Clinical Trials, Randomized Controlled Trial +6
Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study
József Zsíros, Rudolf Maibach, E. Shafford et al. · Journal of Clinical Oncology · 2010 · 322 citations · Full text
[New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)].
Hirokazu Watanabe, Morihito Okada, Yasushi Kaji et al. · PubMed · 2009 · 163 citations
Surgical Oncology, Recist Guideline, Updated Contents +15
Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study
Rochelle Bagatell, Wendy B. London, Lars M. Wagner et al. · Journal of Clinical Oncology · 2010 · 159 citations
The current management of hepatoblastoma: A combination of chemotherapy, conventional resection, and liver transplantation
Gregory M. Tiao, Nicola Bobey, Steven Allen et al. · The Journal of Pediatrics · 2005 · 151 citations
Surgical Oncology, Hepatology, Medicine +10